New Technique in Treating Patients With Liver Cancer Proves Effective

	Tweet

Use of multipolar radiofrequency ablation in the treatment of colorectal liver metastases is effective and has a relatively low recurrence rate, according to a recent study conducted by researchers at Charité, Campus Benjamin Franklin in Berlin, Germany.

“Radiofrequency ablation (RFA) has become a widely used treatment option for patients with primary liver cancer and liver metastases from some primary tumors, if surgery is not an option. However, because of limited sizes of the ablation zones the technique has been limited to tumors smaller than four centimeters,” said Bernd Frericks, MD, lead author of the study.

“This long-term study (four years) was performed using a new multipolar radiofrequency (RF)-device allowing for up to six ablation probes to be used simultaneously, thus providing larger ablation zones. We evaluated this new technique prospectively regarding ablation zone size, technical effectiveness, complications and clinical outcome in patients with colorectal liver metastases,” he said. 

The study evaluated 27 patients with 67 colorectal liver metastases that were treated using multipolar RF ablation. According to the study, complete tumor destruction occurred in 66 of 67 cases. Of the 67 metastases, eight required reablation. After a mean of nine months, 16 patients developed new metastases in the liver and the lung, eight of which were successfully reablated. After four years, 52% of the patients are now tumor-free and 78% are still living.

“Using this new device, the rate of local tumor progressions was not influenced by the size of the tumor to be treated,” said Dr. Frericks.

The full results of this study will be presented on Wednesday, April 16, 2008 during the American Roentgen Ray Society’s annual meeting in Washington, DC.

Source: American Roentgen Ray Society (ARRS)

RELATED STORIES:
Liver Tumors Associated with Metabolic Syndrome Differ from Other Tumors   Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C   Personalized treatment may help some liver cancer patients   Study shows skin rash in patients treated for liver cancer determines survival   Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer   Omega-3 fatty acids inhibit the growth of liver cancer cells   New study confirms link between nonalcoholic steatohepatitis and liver cancer   Sex hormone explains men’s higher liver cancer risk   Liver cancer patients less likely to die on wait list than candidates without carcinomas   A promising molecular target for liver cancer therapy   More Reliable Biomarkers Needed for Liver Cancer Detection   Blacks with Liver Cancer More Likely to Die   Liver transplant recipients almost 3 times more likely to develop cancer   Combination Therapy Improves Survival Time For Patients With Advanced Liver Cancer   Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation   Saffron shows promise in preventing liver cancer   Research in fish provides new clues about deadly form of liver cancer   Metformin May Protect Against Liver Cancer   Scientists identify specific markers that trigger aggressiveness of liver cancer   Experts find rogue stem cells in liver cancer   Cycles of Cell Death, Proliferation Key to Liver Cancer   Type of Anesthesia May Affect Recurrence Risk after Liver Cancer Procedure

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]